alpha 1 proteinase inhibitor (Nektar)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namealpha 1 proteinase inhibitor (Nektar)
Drug Alias NameA1-PI (Nektar)alpha-1 proteinase inhibitor (Aventis Behring/Nektar)alpha-1 proteinase inhibitor (Nektar/Aventis)emphysema therapeutic (Nektar/Aventis)alpha-1 antitrypsin (Aventis/Nektar) +[8] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSerine protease inhibitors
TargetsSerine protease
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNektar Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNektar TherapeuticsCsl Behring Llc
Active IndicationsN/A
Inactive Indicationsalpha 1-Antitrypsin Deficiency

Other Information

ATC CodeN/A
Related LinksN/A